ArticleEClinicalMedicine2021

Efficacy and safety of fevipiprant in patients with uncontrolled asthma: Two replicate, phase 3, randomised, double-blind, placebo-controlled trials (ZEAL-1 and ZEAL-2).

Mario Castro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.